Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG NYSE:JNJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$401.77-0.4%$435.29$396.68▼$603.88$142.79B1.462.51 million shs2.44 million shsJNJJohnson & Johnson$241.23+0.9%$230.50$150.73▼$251.71$575.52B0.268.19 million shs8.13 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-0.35%-0.10%-8.29%-14.25%-23.19%JNJJohnson & Johnson+0.65%+3.33%+2.79%+0.80%+58.42%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$401.77-0.4%$435.29$396.68▼$603.88$142.79B1.462.51 million shs2.44 million shsJNJJohnson & Johnson$241.23+0.9%$230.50$150.73▼$251.71$575.52B0.268.19 million shs8.13 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-0.35%-0.10%-8.29%-14.25%-23.19%JNJJohnson & Johnson+0.65%+3.33%+2.79%+0.80%+58.42%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.67Moderate Buy$573.4242.72% UpsideJNJJohnson & Johnson 2.74Moderate Buy$253.044.90% UpsideCurrent Analyst Ratings BreakdownLatest JNJ and ISRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/15/2026JNJJohnson & Johnson Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)6/12/2026ISRGIntuitive Surgical Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price Target$520.00 ➝ $515.006/2/2026ISRGIntuitive Surgical Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$580.006/2/2026ISRGIntuitive Surgical Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSell$440.00 ➝ $366.005/27/2026ISRGIntuitive Surgical The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$558.005/19/2026ISRGIntuitive Surgical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)5/18/2026ISRGIntuitive Surgical Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$650.00 ➝ $520.005/13/2026JNJJohnson & Johnson Johnson RiceSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Outperform5/13/2026JNJJohnson & Johnson Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$265.004/24/2026JNJJohnson & Johnson Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)4/23/2026ISRGIntuitive Surgical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$712.00 ➝ $651.00(Data available from 6/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$10.06B14.14$9.24 per share43.46$50.52 per share7.95JNJJohnson & Johnson$94.19B6.16$14.25 per share16.93$33.85 per share7.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.86B$8.2548.7040.953.2828.15%15.98%14.07%7/16/2026 (Estimated)JNJJohnson & Johnson$26.80B$8.6527.8919.142.3421.83%32.60%13.29%7/15/2026 (Estimated)Latest JNJ and ISRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/16/2026Q2 2026ISRGIntuitive Surgical$2.48N/AN/AN/A$2.82 billionN/A7/15/2026Q2 2026JNJJohnson & Johnson$2.83N/AN/AN/A$24.96 billionN/A4/21/2026Q1 2026ISRGIntuitive Surgical$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion4/14/2026Q1 2026JNJJohnson & Johnson$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/AJNJJohnson & Johnson$5.362.22%+5.25%61.97%64 YearsLatest JNJ and ISRG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/14/2026JNJJohnson & Johnsonquarterly$1.342.33%5/26/20265/26/20266/9/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A4.613.59JNJJohnson & Johnson0.461.030.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%JNJJohnson & Johnson69.55%Insider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.60%JNJJohnson & Johnson0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical17,021354.16 million352.04 millionOptionableJNJJohnson & Johnson138,2002.41 billion2.40 billionOptionableJNJ and ISRG HeadlinesRecent News About These CompaniesJohnson & Johnson (NYSE:JNJ) Rises As Tech SlipsJune 24 at 6:44 PM | kalkinemedia.comKWhy Is Dividend Stock (NYSE:JNJ) Gaining Attention in the Dow Jones?June 24 at 1:41 PM | kalkinemedia.comK3 Quality Dividend Aristocrats to Buy in JuneJune 24 at 11:00 AM | 247wallst.com3 Quality Dividend Aristocrats to Buy in JuneJune 24 at 10:54 AM | 247wallst.comJohnson & Johnson: Not Every Dollar Needs To Chase The AI Boom (Upgrade)June 24 at 10:10 AM | seekingalpha.comThe Retirement Income Bet That Takes 12 Years To Pay OffJune 24 at 7:02 AM | 247wallst.comWarren Street Wealth Advisors LLC Increases Holdings in Johnson & Johnson $JNJJune 24 at 4:47 AM | marketbeat.comCPC Advisors LLC Acquires 13,185 Shares of Johnson & Johnson $JNJJune 24 at 3:36 AM | marketbeat.comBrookstone Capital Management Has $18.94 Million Holdings in Johnson & Johnson $JNJJune 24 at 3:35 AM | marketbeat.comCampbell Newman Asset Management Inc. Sells 21,646 Shares of Johnson & Johnson $JNJJune 24 at 3:35 AM | marketbeat.comWhy Johnson & Johnson, Altria, Verizon, and Other Safe Dividend Stocks Climbed TodayJune 23 at 9:30 PM | fool.comWhy Johnson & Johnson, Altria, Verizon, and Other Safe Dividend Stocks Climbed TodayJune 23 at 8:50 PM | fool.comHow Oncology, Rare Disease and MedTech Wins At Johnson & Johnson (JNJ) Has Changed Its Investment StoryJune 23 at 7:59 PM | finance.yahoo.comJohnson & Johnson (NYSE:JNJ) Shares Up 3.6% - Still a Buy?June 23 at 5:19 PM | marketbeat.com67 With $1.5 Million. Here Are My 3 Defensive AnchorsJune 23 at 2:58 PM | 247wallst.comThe Cash-Flow Fortress The Stryker Stock Bears Keep MissingJune 23 at 2:58 PM | trefis.comTHow To Build A $7,500 Monthly Paycheck Without Flipping A Single HouseJune 23 at 2:58 PM | 247wallst.comBIO 2026: Drug manufacturers band together to tackle employment challengesJune 23 at 9:56 AM | pharmaceutical-technology.comPShould You Buy Or Sell AbbVie Stock At $230?June 23 at 9:56 AM | trefis.comTJohnson & Johnson $JNJ Shares Purchased by Park National Corp OHJune 23 at 5:03 AM | marketbeat.comFisher Funds Management LTD Sells 32,710 Shares of Johnson & Johnson $JNJJune 23 at 3:44 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 20265 Under-the-Radar AI Stocks to Watch in JuneBy Thomas Hughes | May 31, 2026Will the SpaceX IPO Put These 5 Public Space Stocks Into a Higher Orbit?By Ryan Hasson | June 2, 2026Quantum Stocks Just Got a Lifeline—Who Benefits Most?By Nathan Reiff | May 26, 20263 Dividend Kings That Earn Their Crown Every QuarterBy Chris Markoch | May 31, 2026JNJ and ISRG Company DescriptionsIntuitive Surgical NASDAQ:ISRG$401.77 -1.41 (-0.35%) Closing price 06/24/2026 03:59 PM EasternExtended Trading$400.88 -0.89 (-0.22%) As of 06/24/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.Johnson & Johnson NYSE:JNJ$241.22 +2.15 (+0.90%) Closing price 06/24/2026 03:59 PM EasternExtended Trading$240.00 -1.23 (-0.51%) As of 06/24/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why KB Home Could Reward Patient Investors Later Tesla's New NHTSA Probe Lands at the Worst Possible Time Meta's Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time ASML’s Chip Dominance Runs Into New Silicon Boundaries Frozen Assets: How Super Micro Puts AI Heat on Ice The SpaceX Sell-Off May Be More Than a Market Overreaction Why These South Korea-Focused ETFs Have More Than Doubled in 2026 Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
